The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial Academic Article Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Clinical Trials as Topic
  • Neoadjuvant Therapy
  • Neoplasm, Residual
  • Practice Guidelines as Topic

abstract

  • Among postmenopausal women with osteoporosis, the risk of invasive breast cancer was decreased by 76% during 3 years of treatment with raloxifene.

publication date

  • June 16, 1999

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1001/jama.281.23.2189

PubMed ID

  • 10376571

Additional Document Info

start page

  • 2189

end page

  • 97

volume

  • 281

number

  • 23